back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-10-24 13:18 Tx date 2022-04-13 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
0 | |
| Filed 2023-10-24 13:16 Tx date 2022-04-13 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-220,000 vol |
500,000 | |
| Filed 2023-10-24 13:16 Tx date 2022-04-13 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-200,000 vol |
||
| Filed 2023-10-24 13:15 Tx date 2022-04-13 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
720,000 | |
| Filed 2023-10-24 13:13 Tx date 2022-04-13 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-200,000 vol |
||
| Filed 2023-10-24 13:11 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,572 vol |
||
| Filed 2023-10-24 13:11 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
||
| Filed 2023-10-24 13:09 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-188,571 vol |
||
| Filed 2023-10-24 12:05 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,572 vol |
||
| Filed 2023-10-24 12:05 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,572 vol |
174,286 | |
| Filed 2023-10-24 11:50 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
||
| Filed 2023-10-24 11:50 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
||
| Filed 2023-10-24 11:50 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
174,287 | |
| Filed 2023-10-24 11:47 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
||
| Filed 2023-10-24 11:47 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
602,858 | |
| Filed 2023-10-24 11:46 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-188,571 vol |
||
| Filed 2023-10-24 11:46 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-188,571 vol |
1,031,429 | |
| Filed 2021-02-05 10:03 Tx date 2021-02-04 |
$BUZZ
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$42,500
+500,000 vol $0.085 each |
1,220,000 | |
| Filed 2020-10-15 11:07 Tx date 2020-10-14 |
$NA
Rigel Technologies Inc. (formerly Tele-Find Technologies Corp.) |
Schwartz, Robert
3 - 10% Security Holder of Issuer
Holder: 1469256 Ontario Limited (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,100,000 | ||
| Filed 2020-09-01 17:59 Tx date 2020-08-31 |
$BUZZ
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
720,000 |